Operating incomeEUR 4.8billion
53,155employees worldwide
EUR 5.0billion expenditure in Research and
Development
Development
Human PharmaEUR 18.5billion
thereof10,691in Research, Development and Medicine
equivalent to20.9%of total net sales
Animal HealthEUR 4.6billion
Biopharmaceutical
Contract ManufacturingEUR 1.0billion
Contract ManufacturingEUR 1.0billion